Drugs / Fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04790565 | Apr 2021 → Jun 2022 | — | Rambam Health Care Campus | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal microbiota transplantation | “Fecal microbiota transplantation (FMT), in which fecal material enriched with commensal microorganisms is transferred from a healthy donor, have proven efficacy in the...” NCT04790565 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04790565 ↗ |
| Modality | Other / unclassified | “Fecal microbiota in frozen capsules” NCT04790565 ↗ |
| Route | Oral | “FMT will be given by capsules for 2 consecutive days followed by rectal sampling at predefined time-point in the following 6 months.” NCT04790565 ↗ |